You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

elotuzumab

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Charlotte (Elotuzumab)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Elotuzumab
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 24, 2023

Multiple Myeloma Trial in New York (Iberdomide, Elotuzumab, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • New York, New York
    Icahn School of Medicine
Jan 20, 2023

Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Elotuzumab
  • Belantamab mafodotin
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 15, 2022

Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Relapsed Refractory Multiple Myeloma
  • (no location specified)
Feb 6, 2023

IgG4 Related Disease, IgG4-RD Trial in Atlanta, Boston, Rochester (elotuzumab, for elotuzumab, methylprednisolone)

Recruiting
  • IgG4 Related Disease
  • IgG4-RD
  • elotuzumab
  • +6 more
  • Atlanta, Georgia
  • +2 more
Jul 13, 2022

Multiple Myeloma Trial (Elranatamab, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Nov 28, 2023

Multiple Myeloma Trial in Milwaukee (Isatuximab (for run-in portion), Isatuximab (for expansion), Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Isatuximab (for run-in portion)
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Feb 18, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)

Active, not recruiting
  • Plasma Cell Leukemia
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Elotuzumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Biospecimen Collection
  • +9 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Aug 1, 2023

Multiple Myeloma Trial in United States (Lenalidomide, Elotuzumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +6 more
Dec 17, 2021

Multiple Myeloma Trial (Elotuzumab, Pomalidomide)

Withdrawn
  • Multiple Myeloma
  • (no location specified)
Aug 18, 2021

Multiple Myeloma Trial in Chicago, Evanston, Ann Arbor (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • Chicago, Illinois
  • +2 more
Nov 12, 2021

Multiple Myeloma Trial in Nagoya-shi, Shibukawa-shi, Osaka-shi (Elotuzumab, Lenalidomide, Dexamethasone)

No longer available
  • Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Nagoya-shi, Aichi, Japan
  • +3 more
Nov 17, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • Boston, Massachusetts
  • +5 more
Oct 28, 2021

Multiple Myeloma in Relapse Trial in Denver, Saint Louis, Toronto (Elotuzumab, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma in Relapse
  • Elotuzumab
  • +2 more
  • Denver, Colorado
  • +2 more
Oct 14, 2021

Multiple Myeloma Trial in United States (elotuzumab, Lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • elotuzumab
  • +3 more
  • Denver, Colorado
  • +5 more
Oct 25, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Carfilzomib)

Terminated
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • Encinitas, California
  • +5 more
Mar 15, 2022

Smoldering Myeloma, Smoldering Multiple Myeloma Trial in United States (Elotuzumab, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Myeloma
  • Smoldering Multiple Myeloma
  • Elotuzumab
  • +2 more
  • Denver, Colorado
  • +8 more
Nov 1, 2021

Refractory Plasma Cell Myeloma Trial in Jacksonville (Dexamethasone, Elotuzumab, Pomalidomide)

Suspended
  • Refractory Plasma Cell Myeloma
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 18, 2021

Newly Diagnosed, Previously Untreated Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Elotuzumab)

Terminated
Has Results
  • Newly Diagnosed, Previously Untreated Multiple Myeloma
  • San Francisco, California
  • +13 more
Jun 29, 2021

Multiple Myeloma Trial in Worldwide (Elotuzumab, Dexamethasone, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Elotuzumab
  • +5 more
  • Tucson, Arizona
  • +37 more
Jan 14, 2022

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Elotuzumab
  • +3 more
  • Mobile, Alabama
  • +21 more
Jun 10, 2021

Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)

Active, not recruiting
  • Newly Diagnosed Multiple Myeloma
  • Elotuzumab
  • +4 more
  • Krems, Lower Austria, Austria
  • +55 more
Jan 4, 2022

Recurrent Primary Amyloidosis Trial in United States (drug, biological, other)

Active, not recruiting
  • Recurrent Primary Amyloidosis
  • Duarte, California
  • +4 more
Mar 10, 2021